CN103122347A - 一种杀灭葡萄球菌的裂解酶及其应用 - Google Patents
一种杀灭葡萄球菌的裂解酶及其应用 Download PDFInfo
- Publication number
- CN103122347A CN103122347A CN201310043837XA CN201310043837A CN103122347A CN 103122347 A CN103122347 A CN 103122347A CN 201310043837X A CN201310043837X A CN 201310043837XA CN 201310043837 A CN201310043837 A CN 201310043837A CN 103122347 A CN103122347 A CN 103122347A
- Authority
- CN
- China
- Prior art keywords
- staphylococcus
- lyase
- clyh
- killing
- staphylococcic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000856 Lyases Proteins 0.000 title claims abstract description 41
- 102000004317 Lyases Human genes 0.000 title claims abstract description 40
- 241000191940 Staphylococcus Species 0.000 title claims abstract description 34
- 230000002147 killing effect Effects 0.000 title claims abstract description 23
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 30
- 238000005336 cracking Methods 0.000 claims abstract description 20
- 210000002421 cell wall Anatomy 0.000 claims abstract description 13
- 238000001514 detection method Methods 0.000 claims abstract description 10
- 238000000338 in vitro Methods 0.000 claims abstract description 9
- 238000001727 in vivo Methods 0.000 claims abstract description 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 241000894006 Bacteria Species 0.000 claims description 36
- 230000000694 effects Effects 0.000 claims description 22
- 102000004190 Enzymes Human genes 0.000 claims description 18
- 108090000790 Enzymes Proteins 0.000 claims description 18
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 claims description 10
- 206010041925 Staphylococcal infections Diseases 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 4
- 230000003834 intracellular effect Effects 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 3
- 239000005416 organic matter Substances 0.000 claims description 3
- 241000191967 Staphylococcus aureus Species 0.000 abstract description 54
- 108020004414 DNA Proteins 0.000 abstract description 27
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 abstract description 11
- 229960003085 meticillin Drugs 0.000 abstract description 11
- 230000014509 gene expression Effects 0.000 abstract description 8
- 230000003115 biocidal effect Effects 0.000 abstract description 6
- 210000004027 cell Anatomy 0.000 abstract description 5
- 208000015181 infectious disease Diseases 0.000 abstract description 4
- 102000053602 DNA Human genes 0.000 abstract description 3
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 abstract 2
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 description 25
- 238000013016 damping Methods 0.000 description 21
- 239000012530 fluid Substances 0.000 description 21
- 239000007788 liquid Substances 0.000 description 20
- 238000012360 testing method Methods 0.000 description 16
- 239000000243 solution Substances 0.000 description 13
- 229940088598 enzyme Drugs 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 239000011259 mixed solution Substances 0.000 description 11
- 241000191963 Staphylococcus epidermidis Species 0.000 description 10
- 238000010521 absorption reaction Methods 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 238000000926 separation method Methods 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 238000012408 PCR amplification Methods 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 238000001556 precipitation Methods 0.000 description 6
- 230000004083 survival effect Effects 0.000 description 6
- 238000013461 design Methods 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- 108060001084 Luciferase Proteins 0.000 description 4
- 239000005089 Luciferase Substances 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000003197 catalytic effect Effects 0.000 description 4
- 231100000636 lethal dose Toxicity 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 235000009161 Espostoa lanata Nutrition 0.000 description 3
- 240000001624 Espostoa lanata Species 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 150000001413 amino acids Chemical group 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 231100000433 cytotoxic Toxicity 0.000 description 3
- 230000001472 cytotoxic effect Effects 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 230000000249 desinfective effect Effects 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 238000001502 gel electrophoresis Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 2
- 108010013198 Daptomycin Proteins 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241001147691 Staphylococcus saprophyticus Species 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- DOAKLVKFURWEDJ-QCMAZARJSA-N daptomycin Chemical compound C([C@H]1C(=O)O[C@H](C)[C@@H](C(NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@H](C(=O)N1)[C@H](C)CC(O)=O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)CCCCCCCCC)C(=O)C1=CC=CC=C1N DOAKLVKFURWEDJ-QCMAZARJSA-N 0.000 description 2
- 229960005484 daptomycin Drugs 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000013613 expression plasmid Substances 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- PGHMRUGBZOYCAA-ADZNBVRBSA-N ionomycin Chemical compound O1[C@H](C[C@H](O)[C@H](C)[C@H](O)[C@H](C)/C=C/C[C@@H](C)C[C@@H](C)C(/O)=C/C(=O)[C@@H](C)C[C@@H](C)C[C@@H](CCC(O)=O)C)CC[C@@]1(C)[C@@H]1O[C@](C)([C@@H](C)O)CC1 PGHMRUGBZOYCAA-ADZNBVRBSA-N 0.000 description 2
- PGHMRUGBZOYCAA-UHFFFAOYSA-N ionomycin Natural products O1C(CC(O)C(C)C(O)C(C)C=CCC(C)CC(C)C(O)=CC(=O)C(C)CC(C)CC(CCC(O)=O)C)CCC1(C)C1OC(C)(C(C)O)CC1 PGHMRUGBZOYCAA-UHFFFAOYSA-N 0.000 description 2
- 230000002101 lytic effect Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 239000006158 Baird–Parker agar Substances 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 206010010254 Concussion Diseases 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- 108090000988 Lysostaphin Proteins 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229930192392 Mitomycin Natural products 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 101800004937 Protein C Proteins 0.000 description 1
- 239000012564 Q sepharose fast flow resin Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 102100036546 Salivary acidic proline-rich phosphoprotein 1/2 Human genes 0.000 description 1
- 101800001700 Saposin-D Proteins 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 206010051017 Staphylococcal bacteraemia Diseases 0.000 description 1
- 241000751182 Staphylococcus epidermidis ATCC 12228 Species 0.000 description 1
- 206010066901 Treatment failure Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000941 anti-staphylcoccal effect Effects 0.000 description 1
- 229960005475 antiinfective agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 238000007622 bioinformatic analysis Methods 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 101150084423 femB gene Proteins 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 210000003322 glomus cell Anatomy 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 229960003907 linezolid Drugs 0.000 description 1
- TYZROVQLWOKYKF-ZDUSSCGKSA-N linezolid Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C(C=C1F)=CC=C1N1CCOCC1 TYZROVQLWOKYKF-ZDUSSCGKSA-N 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 229960000856 protein c Drugs 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000012882 sequential analysis Methods 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- VSIVTUIKYVGDCX-UHFFFAOYSA-M sodium;4-[2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)tetrazol-2-ium-5-yl]benzene-1,3-disulfonate Chemical compound [Na+].COC1=CC([N+]([O-])=O)=CC=C1[N+]1=NC(C=2C(=CC(=CC=2)S([O-])(=O)=O)S([O-])(=O)=O)=NN1C1=CC=C([N+]([O-])=O)C=C1 VSIVTUIKYVGDCX-UHFFFAOYSA-M 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310043837.XA CN103122347B (zh) | 2013-02-01 | 2013-02-01 | 一种杀灭葡萄球菌的裂解酶及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310043837.XA CN103122347B (zh) | 2013-02-01 | 2013-02-01 | 一种杀灭葡萄球菌的裂解酶及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103122347A true CN103122347A (zh) | 2013-05-29 |
CN103122347B CN103122347B (zh) | 2015-04-22 |
Family
ID=48453493
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310043837.XA Active CN103122347B (zh) | 2013-02-01 | 2013-02-01 | 一种杀灭葡萄球菌的裂解酶及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103122347B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104211781A (zh) * | 2014-09-04 | 2014-12-17 | 北京纳百景弈生物科技有限公司 | 金黄色葡萄球菌裂解蛋白的制备方法及其应用 |
CN104726439A (zh) * | 2015-04-13 | 2015-06-24 | 武汉赛思锐微生物技术有限公司 | 一种广谱的链球菌裂解酶及其应用 |
CN104762285A (zh) * | 2015-04-23 | 2015-07-08 | 武汉赛思锐微生物技术有限公司 | 一种自内裂解大肠杆菌的裂解酶及其应用 |
CN104805066A (zh) * | 2015-05-18 | 2015-07-29 | 武汉赛思锐微生物技术有限公司 | 一种葡萄球菌裂解酶及其应用 |
CN109666667A (zh) * | 2019-01-22 | 2019-04-23 | 上海交通大学 | 杀灭金黄色葡萄球菌的嵌合酶抗生素及其制备和应用 |
CN110592057A (zh) * | 2019-09-27 | 2019-12-20 | 昆明理工大学 | 嵌合裂解酶ILTphg和编码此酶的多核苷酸 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010002959A2 (en) * | 2008-07-03 | 2010-01-07 | The Rockefeller University | A chimeric bacteriophage lysin with activity against staphylococci bacteria |
WO2011076432A1 (en) * | 2009-12-23 | 2011-06-30 | Hyglos Invest Gmbh | Chimeric polypeptides and their use in bacterial decolonization |
-
2013
- 2013-02-01 CN CN201310043837.XA patent/CN103122347B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010002959A2 (en) * | 2008-07-03 | 2010-01-07 | The Rockefeller University | A chimeric bacteriophage lysin with activity against staphylococci bacteria |
WO2011076432A1 (en) * | 2009-12-23 | 2011-06-30 | Hyglos Invest Gmbh | Chimeric polypeptides and their use in bacterial decolonization |
Non-Patent Citations (4)
Title |
---|
HOLDEN,M.T.G.: "YP_043983.1", 《GENBANK》 * |
LOESSNER,M.J.: "CAA69022.1", 《GENBANK》 * |
MARTIN J. LOESSNER: "Evidence for a Holin-Like Protein Gene Fully Embedded Out of", 《JOURNAL OF BACTERIOLOGY》 * |
姜焕焕: "噬菌体治疗细菌性感染的进展", 《中国生物工程杂志》 * |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104211781A (zh) * | 2014-09-04 | 2014-12-17 | 北京纳百景弈生物科技有限公司 | 金黄色葡萄球菌裂解蛋白的制备方法及其应用 |
CN104726439A (zh) * | 2015-04-13 | 2015-06-24 | 武汉赛思锐微生物技术有限公司 | 一种广谱的链球菌裂解酶及其应用 |
US9993532B2 (en) | 2015-04-13 | 2018-06-12 | Wuhan Phagelux Bio-Tech Company Limited | Broad spectrum of Streptococcus lyase and use thereof |
CN104726439B (zh) * | 2015-04-13 | 2017-11-14 | 武汉菲吉乐科生物科技有限公司 | 一种广谱的链球菌裂解酶及其应用 |
WO2016165604A1 (zh) * | 2015-04-13 | 2016-10-20 | 武汉菲吉乐科生物科技有限公司 | 一种广谱的链球菌裂解酶及其应用 |
CN104762285B (zh) * | 2015-04-23 | 2017-10-27 | 武汉菲吉乐科生物科技有限公司 | 一种自内裂解大肠杆菌的裂解酶及其应用 |
CN104762285A (zh) * | 2015-04-23 | 2015-07-08 | 武汉赛思锐微生物技术有限公司 | 一种自内裂解大肠杆菌的裂解酶及其应用 |
WO2016184274A1 (zh) * | 2015-05-18 | 2016-11-24 | 武汉菲吉乐科生物科技有限公司 | 一种葡萄球菌裂解酶及其应用 |
CN104805066A (zh) * | 2015-05-18 | 2015-07-29 | 武汉赛思锐微生物技术有限公司 | 一种葡萄球菌裂解酶及其应用 |
CN104805066B (zh) * | 2015-05-18 | 2018-04-24 | 武汉菲吉乐科生物科技有限公司 | 一种葡萄球菌裂解酶及其应用 |
EP3299459A4 (en) * | 2015-05-18 | 2018-12-19 | Wuhan Phagelux Bio-Tech Company Limited | Staphylococcus lyase and use thereof |
US10626387B2 (en) | 2015-05-18 | 2020-04-21 | Phagelux, Inc. | Staphylococcus lysin and use thereof |
CN109666667A (zh) * | 2019-01-22 | 2019-04-23 | 上海交通大学 | 杀灭金黄色葡萄球菌的嵌合酶抗生素及其制备和应用 |
CN110592057A (zh) * | 2019-09-27 | 2019-12-20 | 昆明理工大学 | 嵌合裂解酶ILTphg和编码此酶的多核苷酸 |
CN110592057B (zh) * | 2019-09-27 | 2022-01-28 | 昆明理工大学 | 嵌合裂解酶ILTphg和编码此酶的多核苷酸 |
Also Published As
Publication number | Publication date |
---|---|
CN103122347B (zh) | 2015-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103122347B (zh) | 一种杀灭葡萄球菌的裂解酶及其应用 | |
Tremblay et al. | Characterization of the ability of coagulase-negative staphylococci isolated from the milk of Canadian farms to form biofilms | |
Chessa et al. | An overview of Staphylococcus epidermidis and Staphylococcus aureus with a focus on developing countries | |
Jiang et al. | Effect of different disinfectants on bacterial aerosol diversity in poultry houses | |
CN104726439B (zh) | 一种广谱的链球菌裂解酶及其应用 | |
Bhattacharjee et al. | Theragnostic application of nanoparticle and CRISPR against food-borne multi-drug resistant pathogens | |
CN103554225A (zh) | 一组人工合成的抗菌肽及其应用 | |
Silva et al. | Newly isolated lytic bacteriophages for Staphylococcus intermedius, structurally and functionally stabilized in a hydroxyethylcellulose gel containing choline geranate: Potential for transdermal permeation in veterinary phage therapy | |
CN101003793A (zh) | 噬菌体对环境中致病菌的净化技术 | |
CN104805066B (zh) | 一种葡萄球菌裂解酶及其应用 | |
CN102198265B (zh) | 应用噬菌体裂解酶降解猪链球菌生物被膜的方法 | |
CN102121020B (zh) | 一种黄斑蓝子鱼l-氨基酸氧化酶的基因全序列及其用途 | |
Dantur et al. | The endophytic strain Klebsiella michiganensis Kd70 lacks pathogenic island-like regions in its genome and is incapable of infecting the urinary tract in mice | |
KR102203679B1 (ko) | 신규한 엔테로코커스 패시움 균 특이 박테리오파지 ef44 및 이를 포함하는 항균 조성물 | |
CN104840424B (zh) | 一种金丝桃素白蛋白纳米粒‑大肠杆菌血清抗体复合物及其制备方法和应用 | |
Li et al. | Deletion of pbpC enhances bacterial pathogenicity on tomato by affecting biofilm formation, exopolysaccharides production, and exoenzyme activities in Clavibacter michiganensis | |
CN104558121A (zh) | 一种虎纹蛙抗菌肽及其编码基因与应用 | |
CN107841474A (zh) | 一种池生代尔夫特菌及其在水稻稻曲病防治中的应用 | |
De Gaetano et al. | In vivo role of two-component regulatory systems in models of urinary tract infections | |
CN103467580B (zh) | 人工抗菌肽ma-d4的制备方法及其应用 | |
CN105254736B (zh) | 源于缅甸蟒的cathelicidin家族广谱抗微生物肽Pb-CATH4及其基因、制备与应用 | |
Al-shatty | THE USE OF SOLAR STERILIZATION OF SOIL PREPARED FOR FOREST SEEDLING AND ITS EFFECT IN INHIBITING THE GROWTH OF SOIL FUNGI AND MOLECULAR DIAGNOSTICS BY USING PCR TECHNIQUE FUNGI | |
Jedariforoughi | A book about bacteriophage | |
Odetoyin | Occurrence and Diversity of Biofilm Producing Multidrug Resistant Escherichia coli in Dug Wells Used for Domestic Purposes in Ile-Ife, Southwest Nigeria | |
Vazquez | Possible Drivers in Endophyte Diversity and Transmission in the Tomato Plant Bacterial Microbiome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170210 Address after: 430000 East Lake high tech Development Zone, Wuhan Province, high and new avenue, No. 666 (Wuhan Institute of biotechnology, building B7, building 2, B102) Patentee after: Wuhan Kerui Hao Technology Development Co.,Ltd. Address before: 430071 Hongshan, Hubei, Wuchang small central district, No. 44, No. Patentee before: Wuhan Institute of Virology, Chinese Academy of Sciences |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170428 Address after: 430000 Hubei City, Wuchang province No. 87 Bayi Road, building 2, unit 3, building 4, No. 4 Patentee after: Wei Hongping Address before: 430000 East Lake high tech Development Zone, Wuhan Province, high and new avenue, No. 666 (Wuhan Institute of biotechnology, building B7, building 2, B102) Patentee before: Wuhan Kerui Hao Technology Development Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170523 Address after: 430000, Hubei, Wuhan, East Lake Province Development Zone, 666 high-tech Avenue, Wuhan National Bio industrial base project B, C and D District R & D building B1 building, Wuhan Patentee after: Wuhan Phagelux Bio-tech Co.,Ltd. Address before: 430000 Hubei City, Wuchang province No. 87 Bayi Road, building 2, unit 3, building 4, No. 4 Patentee before: Wei Hongping |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221019 Address after: No. 666, Gaoxin Avenue, Donghu High tech Development Zone, Wuhan City, 430000 Hubei Province (B102, Floor 2, Building B7, Wuhan Institute of Biotechnology) Patentee after: Wuhan Kerui Hao Technology Development Co.,Ltd. Address before: B1 / F, R & D building, zone B, C and D, Wuhan National biological industry base project, 666 Gaoxin Avenue, Wuhan East Lake Development Zone, Wuhan City, Hubei Province, 430000 Patentee before: Wuhan Phagelux Bio-tech Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230609 Address after: 430071 No.44, Xiaohongshan Middle District, guoguohu street, Wuchang District, Wuhan City, Hubei Province Patentee after: Wuhan Institute of Virology, Chinese Academy of Sciences Address before: No. 666, Gaoxin Avenue, Donghu High tech Development Zone, Wuhan City, 430000 Hubei Province (B102, Floor 2, Building B7, Wuhan Institute of Biotechnology) Patentee before: Wuhan Kerui Hao Technology Development Co.,Ltd. |
|
TR01 | Transfer of patent right |